These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7142095)

  • 61. [Some investigations on cefadroxil dry syrup (author's transl)].
    Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Hirama Y; Narita A; Chikaoka H; Yamaguchi T
    Jpn J Antibiot; 1981 Feb; 34(2):171-9. PubMed ID: 7253197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cephalexin nephrotoxicity. Reversible nonoliguric acute renal failure and hepatotoxicity associated with cephalexin therapy.
    Fung-Herrera CG; Mulvaney WP
    JAMA; 1974 Jul; 229(3):318-9. PubMed ID: 4406795
    [No Abstract]   [Full Text] [Related]  

  • 63. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
    Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
    Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
    [No Abstract]   [Full Text] [Related]  

  • 64. [Clinical trial in patients with infectious diseases of a new injectable cephalosporin derivative: lysine salt of cephalexin].
    Restivo O; Caruso R
    Arch Maragliano Patol Clin; 1976; 32():37-45. PubMed ID: 1053292
    [No Abstract]   [Full Text] [Related]  

  • 65. [Cefadroxil].
    Fujimori I
    Jpn J Antibiot; 1982 Dec; 35(12):2736-47. PubMed ID: 6763635
    [No Abstract]   [Full Text] [Related]  

  • 66. Cefadroxil in the management of facial cellulitis of odontogenic origin.
    Hanna CB
    Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):496-8. PubMed ID: 2052337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cefadroxil - fewer single administrations in better bioavailability].
    Bauer P; Windorfer A
    ZFA (Stuttgart); 1981 Nov; 57(31):2174-7. PubMed ID: 7314852
    [No Abstract]   [Full Text] [Related]  

  • 68. The use of cefadroxil suspension in children.
    Bannon JA; Foradori GT; Schrogie JJ
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():153-60. PubMed ID: 6815161
    [No Abstract]   [Full Text] [Related]  

  • 69. Cephalexin in the treatment of urinary infection in childhood.
    Glass RD
    Med J Aust; 1973 Apr; 1(16):793-4. PubMed ID: 4575089
    [No Abstract]   [Full Text] [Related]  

  • 70. Prophylactic long-term cephalexin in recurrent urinary infection.
    Fairley KF; Hubbard M; Whitworth JA
    Med J Aust; 1974 Mar; 1(9):318-9. PubMed ID: 4824002
    [No Abstract]   [Full Text] [Related]  

  • 71. [Comparative study of cefaclor and amoxicillin in the treatment of urinary infections].
    Chantrie M
    Acta Urol Belg; 1981 Oct; 49(4):447-51. PubMed ID: 7325095
    [No Abstract]   [Full Text] [Related]  

  • 72. [Clinical results of cefadroxil in children and pharmacokinetics of the drug (author's transl)].
    Takimoto M; Cho K; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1981 Feb; 34(2):140-2. PubMed ID: 7253191
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin.
    Pfau A; Sacks TG
    J Urol; 1989 Nov; 142(5):1276-8. PubMed ID: 2810506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical study of a new cephalosporin in urinary tract infections].
    Micali F; De Angelis A; Corsi M
    Clin Ter; 1978 Jun; 85(6):559-66. PubMed ID: 668275
    [No Abstract]   [Full Text] [Related]  

  • 75. [Peroral cephalosporin. (Our initial results of treatment with cephalexin-Keflex)].
    Tajfl D; Krstić S; Gajić S
    Vojnosanit Pregl; 1973; 30(4):264-8. PubMed ID: 4768021
    [No Abstract]   [Full Text] [Related]  

  • 76. The role of cefadroxil in oral antibiotic therapy. Proceedings of a workshop held in Monte Carlo, Monaco, 13-16 May 1982.
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():1-162. PubMed ID: 7142083
    [No Abstract]   [Full Text] [Related]  

  • 77. A review of the bioavailability of cefadroxil.
    Santella PJ; Henness D
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():17-25. PubMed ID: 7142089
    [No Abstract]   [Full Text] [Related]  

  • 78. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cephalexin (Oracef) in the ambulatory treatment of nonspecific urinary tract infections].
    Kaldewey W
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):63-4. PubMed ID: 401942
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effect of cefadroxil in urinary tract infections].
    Iwao N; Kajikawa H; Kameoka H; Hosokawa S; Nishimoto N; Miyoshi S; Mizutani S
    Jpn J Antibiot; 1984 Apr; 37(4):558-80. PubMed ID: 6471378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.